Biotech

All Articles

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a chat along with Ayla Ellison, Fierce Biotech Managing Editor and Michelle Benz as ...

New records demonstrate how Bayer's asundexian stopped working to avoid movements

.Bayer put on hold the stage 3 test for its own variable XIa inhibitor asundexian behind time in 201...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its own several sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stock up as fund shows intent to mold its evolution

.Galapagos is coming under additional pressure coming from investors. Having created a 9.9% risk in ...

Cell- focused Sana gathers first CSO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shooting...

Allist pays off Jacobio $21M, landing role in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has acquired itself a starring job in China's KRAS market, spending...

ReNeuron leaving purpose swap after missing fundraising objective

.ReNeuron has actually joined the lengthy list of biotechs to leave behind Greater london's intentio...

MBX apply for IPO to take challenger to Ascendis in to period 3

.MBX Biosciences has included in the recent outbreak of IPO filings. The biotech, which filed its do...

FDA increases probe into Lykos' MDMA tests: WSJ

.For Lykos Therapeutics and the firm's would-be MDMA-assisted treatment for post-traumatic stress di...

Gene publisher Tome laying off 131 laborers

.Just days after genetics publisher Volume Biosciences revealed hidden working slices, a more clear ...